Pricing Log in Create free account

Biohaven Ltd. (BHVN) vs Trevi Therapeutics, Inc. (TRVI)

Biohaven Ltd. and Trevi Therapeutics, Inc. are both Biotechnology companies. Biohaven Ltd. and Trevi Therapeutics, Inc. are of similar size ($1.7B and $1.7B). Across the 10 metrics below, Trevi Therapeutics, Inc. leads on 9 and Biohaven Ltd. on 1.

Valuation

Metric BHVN TRVI Biotechnology median
P/E n/m n/m 8.50
P/S 1.63 n/m 9.71
P/B 132.86 5.78 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 1.62 n/m 9.21
Earnings yield (43.04%) (2.86%) (33.15%)
Free cash flow yield (32.74%) (2.84%) (25.50%)

Profitability

Metric BHVN TRVI Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (799.46%) (19.66%) (56.36%)
Return on assets (127.41%) (18.97%) (48.04%)
Return on invested capital (9,245.36%) (1,412.11%) 0.00%

Growth

Metric BHVN TRVI Biotechnology median
Revenue growth (TTM) 425.20% — 6.02%
EPS growth (last fiscal year) 26.08% 31.91% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BHVN TRVI Biotechnology median
Debt to equity 21.23 0.00 0.00
Current ratio 4.73 37.28 4.72
Net debt to EBITDA 0.11 3.83 0.96

Dividend

Metric BHVN TRVI Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric BHVN TRVI Biotechnology median
Market cap 1.73b 1.73b 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack